Method for preservation of nitrile hydration activity.
Abstract
This record has no abstract on file.
Term
Term ended
Expired 30 April 2007, 19.4 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
4 claims: 1 independent, 3 dependent
- 1A method for preservation of the nitrile hydration activity of nitrilase produced by a Gram-positive microorganism or of an immobilized form thereof, both having nitrile hydration activity, which method comprises adding as a stabilizer at least one compound selected from the group consisting of amides and organic acids and salts thereof to a solution or suspension of said nitrilase or of said immobilized form thereof.
55 paragraphs in 2 sections, as filed
0001The present invention relates to a method for prevention of reduction with elapse of time in nitrile hydration activity of nitrilase produced by specific microorganisms and for stable preservation of this activity.
0002In recent years, the technology of immobilized enzymes and microorganisms has developed rapidly, resulting in increasing attempts to utilize microorganisms and enzymes as they are or in the immobilized state as catalysts for various single or complex chemical reactions.
0003Nitrilase has been known as an enzyme capable of hydrating nitriles to produce the corresponding amides. As examples of the utilization of this enzyme, methods for producing (meth)acrylamide from (meth)acrylonitrile with the use of microorganisms of the genus <u style="single">Corynebacterium</u> or <u style="single">Nocardia</u> which produce nitrilase (Reference: Japanese Patent Pub. No. 17918/1981); for producing from C₂₋₄ nitriles the corresponding amides with the use of microorganisms of the genus <u style="single">Rhodococcus</u> (Reference: Japanese Patent Appln. No. 452/1985); and for producing from nitriles the corresponding amides with the use of microorganisms of the genus <u style="single">Bacillus</u>, <u style="single">Bacteridium</u>, <u style="single">Micrococcus</u> or <u style="single">Brevibacterium</u> (Reference: Japanese Patent Laid-Open Pub. No. 86186/1976) have been proposed.
0004As a result of further investigation, however, we have found that the nitrile hydration activity of the above mentioned nitrilase is labile and decreases as the temperature rises or the purity of the enzyme increases. This decrease occurs also with immobilized enzymes.
SUMMARY OF THE INVENTION
0005As a result of extensive research effort expended toward solving the above problems and efficiently utilizing the nitrile hydration activity of nitrilase, we have found that specific substances, i.e., amides and organic acids or salts therof, is very effective for this purpose and have arrived at the present invention on the basis of this finding.
0006More specifically, the present invention provides a method for preservation of the nitrile hydration activity of nitrilase produced by a Gram-positive microorganism or of an immobilized form thereof, both having nitrile hydration activity, which method comprises adding as a stabilizer at least one compound selected from the group consisting of amides and organic acids and salts therof to a solution or supension of said nitrilase or of said immobilized form thereof.
DETAILED DESCRIPTION OF THE INVENTION
Microorganism:
0007The microorganisms used in the present invention are specific ones capable of producing nitrilase and hydrating nitriles, especially acrylonitrile, to produce the corresponding amides, especially acrylamide. Specific examples of such microorganisms are strains N-771 (FERM P-4445) and N-774 (FERM P-4446)of the genus <u style="single">Corynebacterium</u> and strain N-775 (FERM P-4447) of the genus <u style="single">Nocardia</u> disclosed in Japanese Patent Publ. No. 17918/1 81 mentioned above and corresponding to U.S. Patent 4,248,968 (February 3, 1986), strain sp. S-6 (FERM BP-687) of the genus <u style="single">Rhodococcus</u> disclosed in Japanese Patent Appln. No. 452/1985 again mentioned above and corresponding to European Patent Pub. 0 188 316 A1 (July 23, 1986), and strains of the genera <u style="single">Bacillus</u>, <u style="single">Bacterium</u>, <u style="single">Micrococcus</u> and <u style="single">Brevibacterium</u> disclosed in Japanese Patent Laid-Open Pub. No. 86186/1976 and corresponding to U.S. Patent 4,001,081, mentioned previously.
0008Cultivation of these microorganisms is ordinarily carried out under aerobic conditions by inoculating strains of the respective microorganisms into culture media containing: carbon sources such as glucose, sucrose, dextrins and glycerol; nitrogen sources such as ammonium sulfate and urea; organic nutrient sources such as yeast extract, meat extract, malt extract and peptone; and other optional ingredients.
0009The pH of the culture medium is of the order of 5 to 9, preferably of the order of 6 to 8, while the cultivation temperature is of the order of 20 to 37°C, preferably of the order of 20 to 30°C, and the cultivation time is about 1 to 3 days. Cells obtained by the cultivation can be collected for example, by centrifugation.
Nitrilase:
0010The nitrilase used in the present invention is an enzyme produced by the aforementioned microorganisms and irradiation with light rays is required in order to induce its activity to the fullest extent (Reference: Japanese Patent Appln. No. 2724/1985). This enzyme can be separated and extracted by the following procedure.
0011First, the cells collected from the culture fluid by centrifugation and the like are suspended in a buffer in a quantity sufficient to reach a given cell concentration and crushed in an ultrasonic cell crusher, Daino mill or French press. Uncrushed cells and cell walls or membranes are removed, for example, by centrifugation to obtain a soluble fraction (cell extract). The cell extract thus obtained is purified by a conventional method such as ammonium sulfate fractionation, DEAE-Sephacel Phenyl-Sepharose® or Sephadex® column chromatography or crystallization whereby a partly purified enzyme solution or a purified enzyme (solution) can be obtained.
0012Both these enzymes can be used in the present invention irrespective of whether they are purified partly or completely.
Immobilized Enzyme:
0013The immobilized enzymes of the present invention can be obtained by subjecting the above stated nitrilase to the adsorption method which involves adsorption onto activated carbon and the like, the ionic bond method which involves bonding to ion exchange resins and the like, the covalently bonding method which involves covalently bonding to glass beads, and the entrapping method which involves entrapping with acrylamide, carrageenan, alginate and the like in accordance with a conventional method.
Stabilizer:
0014The stabilizers used in the present invention are compounds selected from amides, and organic acids and salts thereof, and these compounds can be used singly or in combination.
0015Specific examples of such compounds are: <ul id="ul0001" list-style="none"><li>(1) Aliphatic amides, such as acetamide, propionamide and isobutyramide and the corresponding acids or salts thereof.</li><li>(2) Aminoacidamides such as glycine amides, α-aminopropionamide and β-aminopropionamide and the corresponding acids or salts thereof.</li><li>(3) Hydroxy-carboxylic acid amides such as lactamide, hydroxyacetamide and β-hydroxypropionamide and the corresponding acids or salts thereof.</li><li>(4) Unsaturated amides such as acrylamide and methacrylamide and the corresponding acids or salts thereof.</li><li>(5) Diamides such as malondiamide, succindiamide and adipic acid diamide and the corresponding dibasic acids or salts thereof.</li><li>(6) Aromatic amides such as benzamide and phenylacetamide and the corresponding acids or salts thereof.</li><li>(7) Heterocyclic amides such as nicotinamide and isonicotinamide and the corresponding acids or salts thereof.</li><li>(8) Halogenated amides such as chloroacetamide and β -chloropropionamide and the corresponding acids or salts thereof.</li><li>(9) Acids having an aldehyde group such as glyoxylic acid or salts thereof.</li></ul>
Preservation of Nitrile Hydration Activity:
0016The preservation of nitrile hydration activity can be attained by adding any of the above enumerated compounds to a solution or suspension of the previously mentioned nitrilase or an immobilized form thereof dissolved or dispersed in various buffers or physiological saline. Ordinarily, the quantity of the stabilizer added is in the range of from 0.01 to 50 g/l but 0.1 to 10 g/l of the stabilizer is preferably added from the point of view of storage stability, cost and the like.
0017The pH of the solution or suspension is 5 to 8, preferably 5.5 to 7, and a variety of buffers such as phosphate buffer and Tris buffer are ordinarily employed. In some cases, it may be effective to control pH by adding an acid such as hydrochloric acid or sulfuric acid or an alkali such as caustic soda or caustic potash.
0018While the solution or suspension thus obtained may be stored at room temperature as long as the storage period is short, storage at a low temperature, especially at a temperature in the vicinity of 0°C is preferred.
0019In accordance with the present invention, nitrile hydration activity can be preserved stably over a long period of time. This effect is observed not only in the storage stability of the enzyme solution at the respective stages of the enzyme purification described previously but also in the preservation of the enzyme activity in each purification step. It is therefore preferable that the stabilizer be added to the enzyme solution or buffer used in each purification step.
0020In order to indicate more fully the nature and utility of this invention, the following specific examples of practice are set forth, it being understood that these examples are presented as illustrative only and not intended to limit the scope of the invention.
Experimental Examples
0021In each of the following experimental examples, 0.1 ml of an enzyme solution was charged into a beaker containing 9.9 ml of phosphate buffer and irradiated with a 100-W EYE LAMP (supplied by Toshiba, Japan) positioned at a distance of 50 cm for 30 minutes in a bath maintained at 10°C to induce the enzyme activity to the fullest extent. The resulting solution was then added to 10 ml of M/20 phosphate buffer (pH 7.7) containing 5.0% by weight of acrylonitrile to cause reaction at 10°C for 10 minutes. The nitrile hydration activity of the test enzyme solution was determined by measuring the quantity of acrylamide produced by gas chromatography, the capability of producing 1 µ mole of acrylamide per ml of the enzyme solution per minute being designated as 1 unit (U).
Example 1 and Comparison Example 1
0022A culture medium comprising 10 g/l of glucose, 5 g/l of peptone, 3 g/l of yeast extract, and 3 g/l of malt extract was adjusted to a pH of 7.2, and 100 ml of the resulting culture medium was sterilized in a 500-ml Erlenmeyer flask.
0023After cooling, the sterilized culture medium was inoculated with 1 ml of a culture fluid obtained by precultivating strain N-774(FERM P-4446) of the genus <u style="single">Corynebacterium</u> in the same culture medium as is described above for 2 days, and cultivation was carried out aerobically at 30°C for 2 days.
0024Cells were separated from the culture fluid by centrifugation (3°C, 10,000 rpm, 20 minutes) and washed with a physiological saline. The washed cells were subjected to centrifugation under the same conditions and then suspended in a physiological saline to obtain a suspension of washed cells.
0025Subsequently, 50 ml of this cell suspension was mixed with 50 ml of M/10 phosphate buffer (pH 6.5) containing 10 g/l of ammonium isobutyrate (2.5x10³ U/ml).
0026The resultant cell suspension was pressed in a French press (fabricated by Ohtake Seisaku-sho, Japan) to crush cells under a pressure of 1,000 to 1,500 kg G and then subjected to centrifugation (12,000 rpm, 30 minutes) to remove uncrushed cells and insolubles such as cell walls, whereby a cell extract, i.e. a crude enzyme solution, was obtained.
0027For comparison purposes, a similar cell suspension (2.5x10³ U/ml) which contained no ammonium isobutyrate was prepared and subjected to a French press treatment and centrifugation under similar conditions, whereby a control cell extract was obtained.
0028Both cell extracts were left standing for 2 days at 20°C, and the nitrile hydration activity levels were measured before and after the extracts were left standing. The residual nitrile hydration activity percent (in Table 1, as in all succeeding tables, abbreviated to % residual activity) was calculated on the basis of the data thus obtained. The results are shown in Table 1. <tables id="tabl0001" num="0001"><table frame="all"><title>Table 1</title><tgroup cols="5" colsep="1" rowsep="1"><colspec colnum="1" colname="col1" colwidth="31.50mm" /><colspec colnum="2" colname="col2" colwidth="31.50mm" /><colspec colnum="3" colname="col3" colwidth="31.50mm" /><colspec colnum="4" colname="col4" colwidth="31.50mm" /><colspec colnum="5" colname="col5" colwidth="31.50mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" align="center">Experimental Example</entry><entry namest="col2" nameend="col2" align="center">Ammonium Isobutyrate</entry><entry namest="col3" nameend="col3" align="center">Activity Before Being Left Standing (U/ml)</entry><entry namest="col4" nameend="col4" align="center">Activity After Being Left Standing (U/ml)</entry><entry namest="col5" nameend="col5" align="center">% Residual Activity</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">Example 1</entry><entry namest="col2" nameend="col2" align="center">Added</entry><entry namest="col3" nameend="col3" align="char" char=".">1.3 x 10³</entry><entry namest="col4" nameend="col4" align="center">1.2 x 10³</entry><entry namest="col5" nameend="col5" align="right">92</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Comparison Example 1</entry><entry namest="col2" nameend="col2" align="center">None</entry><entry namest="col3" nameend="col3" align="char" char=".">1.2 x 10³</entry><entry namest="col4" nameend="col4" align="center">0.33 x 10³</entry><entry namest="col5" nameend="col5" align="right">28</entry></row></tbody></tgroup></table></tables>
Examples 2 through 6 and Comparison Examples 2 through 6
0029Each aliquot of a suspension of cells of a genus as shown in Table 2 prepared as in Comparison Example 1 was subjected to French press treatment and centrifugation similarly as in Comparison Example 1, whereby a cell extract was obtained.
0030The cell extract thus obtained was divided into two aliquots, 1 ml of one aliquot being mixed with 1 ml of M/10 phosphate buffer (pH 6.5) containing 10 g/l of ammonium isobutyrate, and 1 ml of the other aliquot being mixed with 1 ml of M/10 phosphate buffer (pH 6.5) as a comparison example. Both solutions were left standing for 2 days at 20°C, and the nitrile hydration activity levels were measured before and after each of the solutions was left standing to calculate % residual activity. The results obtained are summarized in Table 2. <tables id="tabl0002" num="0002"><table frame="all"><title>Table 2</title><tgroup cols="4" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="39.37mm" /><colspec colnum="2" colname="col2" colwidth="39.37mm" /><colspec colnum="3" colname="col3" colwidth="39.37mm" /><colspec colnum="4" colname="col4" colwidth="39.37mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" align="center">Experimental Example</entry><entry namest="col2" nameend="col2" align="center">Genus</entry><entry namest="col3" nameend="col3" align="center">Strain</entry><entry namest="col4" nameend="col4" align="center">% Residual Activity</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="right">Example 2</entry><entry namest="col2" nameend="col2" align="left">Bacillus</entry><entry namest="col3" nameend="col3" align="center">CBS-494</entry><entry namest="col4" nameend="col4" align="right">83</entry></row><row><entry namest="col1" nameend="col1" align="right">3</entry><entry namest="col2" nameend="col2" align="left">Bacteridium</entry><entry namest="col3" nameend="col3" align="center">CBS-496</entry><entry namest="col4" nameend="col4" align="right">78</entry></row><row><entry namest="col1" nameend="col1" align="right">4</entry><entry namest="col2" nameend="col2" align="left">Micrococcus</entry><entry namest="col3" nameend="col3" align="center">CBS-497</entry><entry namest="col4" nameend="col4" align="right">91</entry></row><row><entry namest="col1" nameend="col1" align="right">5</entry><entry namest="col2" nameend="col2" align="left">Brevibacterium</entry><entry namest="col3" nameend="col3" align="center">CBS-717</entry><entry namest="col4" nameend="col4" align="right">89</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="right">6</entry><entry namest="col2" nameend="col2" align="left">Nocardia</entry><entry namest="col3" nameend="col3" align="center">N-775</entry><entry namest="col4" nameend="col4" align="right">93</entry></row><row><entry namest="col1" nameend="col1" align="right">Comparison Example 2</entry><entry namest="col2" nameend="col2" align="left">Bacillus</entry><entry namest="col3" nameend="col3" align="center">CBS-494</entry><entry namest="col4" nameend="col4" align="right">23</entry></row><row><entry namest="col1" nameend="col1" align="right">3</entry><entry namest="col2" nameend="col2" align="left">Bacteridium</entry><entry namest="col3" nameend="col3" align="center">CBS-496</entry><entry namest="col4" nameend="col4" align="right">26</entry></row><row><entry namest="col1" nameend="col1" align="right">4</entry><entry namest="col2" nameend="col2" align="left">Micrococcus</entry><entry namest="col3" nameend="col3" align="center">CBS-497</entry><entry namest="col4" nameend="col4" align="right">30</entry></row><row><entry namest="col1" nameend="col1" align="right">5</entry><entry namest="col2" nameend="col2" align="left">Brevibacterium</entry><entry namest="col3" nameend="col3" align="center">CBS-717</entry><entry namest="col4" nameend="col4" align="right">22</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="right">6</entry><entry namest="col2" nameend="col2" align="left">Nocardia</entry><entry namest="col3" nameend="col3" align="center">N-775</entry><entry namest="col4" nameend="col4" align="right">24</entry></row></tbody></tgroup></table></tables>
Examples 7 through 24 and Comparison Example 7
0031To each 2.5-ml aliquot of a cell extract (0.8x10³ U/ml) prepared as in Comparison Example 1, was added 2.5 ml of M/10 phosphate buffer containing 10 mg of an amide as shown in Table 3. The pH of the solution was adjusted to 6.5, and the resulting solution was then left standing at 20°C for 2 days. The % residual activity was calculated similarly as in the preceding Examples, whereupon the results set forth in Table 3 were obtained. <tables id="tabl0003" num="0003"><table frame="all"><title>Table 3</title><tgroup cols="3" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="52.50mm" /><colspec colnum="2" colname="col2" colwidth="52.50mm" /><colspec colnum="3" colname="col3" colwidth="52.50mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" align="center">Experimental Example</entry><entry namest="col2" nameend="col2" align="center">Amide Added</entry><entry namest="col3" nameend="col3" align="center">% Residual Activity</entry></row></thead><tbody valign="top"><row rowsep="1"><entry namest="col1" nameend="col1" align="right">Comparison Example 7</entry><entry namest="col2" nameend="col2" align="left">None</entry><entry namest="col3" nameend="col3" align="right">21</entry></row><row><entry namest="col1" nameend="col1" align="right">Example 7</entry><entry namest="col2" nameend="col2" align="left">Acetamide</entry><entry namest="col3" nameend="col3" align="right">57</entry></row><row><entry namest="col1" nameend="col1" align="right">8</entry><entry namest="col2" nameend="col2" align="left">Propionamide</entry><entry namest="col3" nameend="col3" align="right">83</entry></row><row><entry namest="col1" nameend="col1" align="right">9</entry><entry namest="col2" nameend="col2" align="left">n-Butyramide</entry><entry namest="col3" nameend="col3" align="right">90</entry></row><row><entry namest="col1" nameend="col1" align="right">10</entry><entry namest="col2" nameend="col2" align="left">Isobutyramide</entry><entry namest="col3" nameend="col3" align="right">85</entry></row><row><entry namest="col1" nameend="col1" align="right">11</entry><entry namest="col2" nameend="col2" align="left">n-Valeramide</entry><entry namest="col3" nameend="col3" align="right">78</entry></row><row><entry namest="col1" nameend="col1" align="right">12</entry><entry namest="col2" nameend="col2" align="left">n-Capronamide</entry><entry namest="col3" nameend="col3" align="right">75</entry></row><row><entry namest="col1" nameend="col1" align="right">13</entry><entry namest="col2" nameend="col2" align="left">Glycine amide</entry><entry namest="col3" nameend="col3" align="right">49</entry></row><row><entry namest="col1" nameend="col1" align="right">14</entry><entry namest="col2" nameend="col2" align="left">β-Aminopropionamide</entry><entry namest="col3" nameend="col3" align="right">52</entry></row><row><entry namest="col1" nameend="col1" align="right">15</entry><entry namest="col2" nameend="col2" align="left">Lactamide</entry><entry namest="col3" nameend="col3" align="right">50</entry></row><row><entry namest="col1" nameend="col1" align="right">16</entry><entry namest="col2" nameend="col2" align="left">β-Hydroxypropionamide</entry><entry namest="col3" nameend="col3" align="right">61</entry></row><row><entry namest="col1" nameend="col1" align="right">17</entry><entry namest="col2" nameend="col2" align="left">Acrylamide</entry><entry namest="col3" nameend="col3" align="right">63</entry></row><row><entry namest="col1" nameend="col1" align="right">18</entry><entry namest="col2" nameend="col2" align="left">Methacrylamide</entry><entry namest="col3" nameend="col3" align="right">70</entry></row><row><entry namest="col1" nameend="col1" align="right">19</entry><entry namest="col2" nameend="col2" align="left">Malondiamide</entry><entry namest="col3" nameend="col3" align="right">48</entry></row><row><entry namest="col1" nameend="col1" align="right">20</entry><entry namest="col2" nameend="col2" align="left">Succindiamide</entry><entry namest="col3" nameend="col3" align="right">63</entry></row><row><entry namest="col1" nameend="col1" align="right">21</entry><entry namest="col2" nameend="col2" align="left">Benzamide</entry><entry namest="col3" nameend="col3" align="right">47</entry></row><row><entry namest="col1" nameend="col1" align="right">22</entry><entry namest="col2" nameend="col2" align="left">Nicotinamide</entry><entry namest="col3" nameend="col3" align="right">39</entry></row><row><entry namest="col1" nameend="col1" align="right">23</entry><entry namest="col2" nameend="col2" align="left">Chloroacetamide</entry><entry namest="col3" nameend="col3" align="right">60</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="right">24</entry><entry namest="col2" nameend="col2" align="left">β-Chloropropionamide</entry><entry namest="col3" nameend="col3" align="right">68</entry></row></tbody></tgroup></table></tables>
Examples 25 through 41 and Comparison Example 8
0032The procedures of Examples 7 through 24 were followed except that the amides added were replaced by organic acids and that the pH of the solution was adjusted to 6.5. The results obtained are set forth in Table 4. <tables id="tabl0004" num="0004"><table frame="all"><title>Table 4</title><tgroup cols="3" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="52.50mm" /><colspec colnum="2" colname="col2" colwidth="52.50mm" /><colspec colnum="3" colname="col3" colwidth="52.50mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" align="center">Experimental Example</entry><entry namest="col2" nameend="col2" align="center">Organic Acid Added</entry><entry namest="col3" nameend="col3" align="center">% Residual Activity</entry></row></thead><tbody valign="top"><row rowsep="1"><entry namest="col1" nameend="col1" align="right">Comparison Example 8</entry><entry namest="col2" nameend="col2" align="left">None</entry><entry namest="col3" nameend="col3" align="right">21</entry></row><row><entry namest="col1" nameend="col1" align="right">Example 25</entry><entry namest="col2" nameend="col2" align="left">Formic acid</entry><entry namest="col3" nameend="col3" align="right">48</entry></row><row><entry namest="col1" nameend="col1" align="right">26</entry><entry namest="col2" nameend="col2" align="left">Acetic acid</entry><entry namest="col3" nameend="col3" align="right">55</entry></row><row><entry namest="col1" nameend="col1" align="right">27</entry><entry namest="col2" nameend="col2" align="left">Propionic acid</entry><entry namest="col3" nameend="col3" align="right">78</entry></row><row><entry namest="col1" nameend="col1" align="right">28</entry><entry namest="col2" nameend="col2" align="left">Isobutyric acid</entry><entry namest="col3" nameend="col3" align="right">83</entry></row><row><entry namest="col1" nameend="col1" align="right">29</entry><entry namest="col2" nameend="col2" align="left">Valeric acid</entry><entry namest="col3" nameend="col3" align="right">81</entry></row><row><entry namest="col1" nameend="col1" align="right">30</entry><entry namest="col2" nameend="col2" align="left">Caproic acid</entry><entry namest="col3" nameend="col3" align="right">78</entry></row><row><entry namest="col1" nameend="col1" align="right">31</entry><entry namest="col2" nameend="col2" align="left">β-Aminopropionic acid</entry><entry namest="col3" nameend="col3" align="right">45</entry></row><row><entry namest="col1" nameend="col1" align="right">32</entry><entry namest="col2" nameend="col2" align="left">Malic acid</entry><entry namest="col3" nameend="col3" align="right">43</entry></row><row><entry namest="col1" nameend="col1" align="right">33</entry><entry namest="col2" nameend="col2" align="left">Glycolic acid</entry><entry namest="col3" nameend="col3" align="right">52</entry></row><row><entry namest="col1" nameend="col1" align="right">34</entry><entry namest="col2" nameend="col2" align="left">DL-Glyceric acid</entry><entry namest="col3" nameend="col3" align="right">60</entry></row><row><entry namest="col1" nameend="col1" align="right">35</entry><entry namest="col2" nameend="col2" align="left">Oxalacetic acid</entry><entry namest="col3" nameend="col3" align="right">68</entry></row><row><entry namest="col1" nameend="col1" align="right">36</entry><entry namest="col2" nameend="col2" align="left">Succinic acid</entry><entry namest="col3" nameend="col3" align="right">59</entry></row><row><entry namest="col1" nameend="col1" align="right">37</entry><entry namest="col2" nameend="col2" align="left">Benzoic acid</entry><entry namest="col3" nameend="col3" align="right">48</entry></row><row><entry namest="col1" nameend="col1" align="right">38</entry><entry namest="col2" nameend="col2" align="left">Monochloroacetic acid</entry><entry namest="col3" nameend="col3" align="right">39</entry></row><row><entry namest="col1" nameend="col1" align="right">39</entry><entry namest="col2" nameend="col2" align="left">Glyoxylic acid</entry><entry namest="col3" nameend="col3" align="right">72</entry></row><row><entry namest="col1" nameend="col1" align="right">40</entry><entry namest="col2" nameend="col2" align="left">Acrylic acid</entry><entry namest="col3" nameend="col3" align="right">53</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="right">41</entry><entry namest="col2" nameend="col2" align="left">Methacrylic acid</entry><entry namest="col3" nameend="col3" align="right">59</entry></row></tbody></tgroup></table></tables>
Examples 42 through 50 and Comparison Examples 9 through 12
.
0033To each 2.5 ml aliquot of a cell extract (1.8x10³ U/ml) prepared as in Comparison Example 1, was added 2.5 ml of M/10 phosphate buffer containing 25 mg of a stabilizer as shown in Table 5. The pH of the solution was adjusted to a predetermined level, and the resulting solution was left standing at 20°C for 2 days.
0034The nitrile hydration activity levels were measured before and after each of the solutions was left standing to calculate % residual activity. The results obtained are summarized in Table 6. <tables id="tabl0005" num="0005"><table frame="all"><title>Table 5</title><tgroup cols="4" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="39.37mm" /><colspec colnum="2" colname="col2" colwidth="39.37mm" /><colspec colnum="3" colname="col3" colwidth="39.37mm" /><colspec colnum="4" colname="col4" colwidth="39.37mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" align="center">Experimental Example</entry><entry namest="col2" nameend="col2" align="center">Stabilizer Added</entry><entry namest="col3" nameend="col3" align="center">pH</entry><entry namest="col4" nameend="col4" align="center">% Residual Activity</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="right">Comparison Example 9</entry><entry namest="col2" nameend="col2" align="center">None</entry><entry namest="col3" nameend="col3" align="char" char=".">5.0</entry><entry namest="col4" nameend="col4" align="right">4</entry></row><row><entry namest="col1" nameend="col1" align="right">10</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">6.0</entry><entry namest="col4" nameend="col4" align="right">13</entry></row><row><entry namest="col1" nameend="col1" align="right">11</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">7.0</entry><entry namest="col4" nameend="col4" align="right">27</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="right">12</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">8.0</entry><entry namest="col4" nameend="col4" align="right">32</entry></row><row><entry namest="col1" nameend="col1" align="right">Example 42</entry><entry namest="col2" nameend="col2" align="center">Isobutyramide</entry><entry namest="col3" nameend="col3" align="char" char=".">5.0</entry><entry namest="col4" nameend="col4" align="right">4</entry></row><row><entry namest="col1" nameend="col1" align="right">43</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">6.0</entry><entry namest="col4" nameend="col4" align="right">80</entry></row><row><entry namest="col1" nameend="col1" align="right">44</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">7.0</entry><entry namest="col4" nameend="col4" align="right">74</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="right">45</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">8.0</entry><entry namest="col4" nameend="col4" align="right">48</entry></row><row><entry namest="col1" nameend="col1" align="right">Example 46</entry><entry namest="col2" nameend="col2" align="center">Isobutyric acid</entry><entry namest="col3" nameend="col3" align="char" char=".">5.0</entry><entry namest="col4" nameend="col4" align="right">2</entry></row><row><entry namest="col1" nameend="col1" align="right">47</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">5.5</entry><entry namest="col4" nameend="col4" align="right">82</entry></row><row><entry namest="col1" nameend="col1" align="right">48</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">6.0</entry><entry namest="col4" nameend="col4" align="right">83</entry></row><row><entry namest="col1" nameend="col1" align="right">49</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">7.0</entry><entry namest="col4" nameend="col4" align="right">77</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="right">50</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">8.0</entry><entry namest="col4" nameend="col4" align="right">42</entry></row></tbody></tgroup></table></tables>
Examples 51 through 62 and Comparison Example 13
0035To each 2.5-ml aliquot of a cell extract (0.7x10³ U/ml) prepared as in Comparison Example 1, was added 2.5 ml of M/10 phosphate buffer containing a predetermined quantity of a stabilizer as shown in Table 6. The pH of the solution was adjusted to 6.0 (6.5 for the solution containing no stabilizer), and the resulting solution was then left standing at 20°C for 2 days.
0036The nitrile hydration activity levels were measured before and after each of the solutions was left standing to calculate % residual activity. The results are set forth in Table 6. <tables id="tabl0006" num="0006"><table frame="all"><title>Table 6</title><tgroup cols="4" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="39.37mm" /><colspec colnum="2" colname="col2" colwidth="39.37mm" /><colspec colnum="3" colname="col3" colwidth="39.37mm" /><colspec colnum="4" colname="col4" colwidth="39.37mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" align="center">Experimental Example</entry><entry namest="col2" nameend="col2" align="center">Stabilizer Added</entry><entry namest="col3" nameend="col3" align="center">Concentration (g/l)</entry><entry namest="col4" nameend="col4" align="center">% Residual Activity</entry></row></thead><tbody valign="top"><row rowsep="1"><entry namest="col1" nameend="col1" align="right">Comparison Example 13</entry><entry namest="col2" nameend="col2" align="center">None</entry><entry namest="col3" nameend="col3" align="char" char=".">-</entry><entry namest="col4" nameend="col4" align="right">17</entry></row><row><entry namest="col1" nameend="col1" align="right">Example 51</entry><entry namest="col2" nameend="col2" align="center">Butyramide</entry><entry namest="col3" nameend="col3" align="char" char=".">0.01</entry><entry namest="col4" nameend="col4" align="right">60</entry></row><row><entry namest="col1" nameend="col1" align="right">52</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">0.1</entry><entry namest="col4" nameend="col4" align="right">85</entry></row><row><entry namest="col1" nameend="col1" align="right">53</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">1.0</entry><entry namest="col4" nameend="col4" align="right">85</entry></row><row><entry namest="col1" nameend="col1" align="right">54</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">5.0</entry><entry namest="col4" nameend="col4" align="right">89</entry></row><row><entry namest="col1" nameend="col1" align="right">55</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">20</entry><entry namest="col4" nameend="col4" align="right">78</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="right">56</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">50</entry><entry namest="col4" nameend="col4" align="right">63</entry></row><row><entry namest="col1" nameend="col1" align="right">Example 57</entry><entry namest="col2" nameend="col2" align="center">Butyric acid</entry><entry namest="col3" nameend="col3" align="char" char=".">0.01</entry><entry namest="col4" nameend="col4" align="right">63</entry></row><row><entry namest="col1" nameend="col1" align="right">58</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">0.1</entry><entry namest="col4" nameend="col4" align="right">87</entry></row><row><entry namest="col1" nameend="col1" align="right">59</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">1.0</entry><entry namest="col4" nameend="col4" align="right">92</entry></row><row><entry namest="col1" nameend="col1" align="right">60</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">5.0</entry><entry namest="col4" nameend="col4" align="right">90</entry></row><row><entry namest="col1" nameend="col1" align="right">61</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">20</entry><entry namest="col4" nameend="col4" align="right">85</entry></row><row><entry namest="col1" nameend="col1" align="right">62</entry><entry namest="col2" nameend="col2" align="center">"</entry><entry namest="col3" nameend="col3" align="char" char=".">50</entry><entry namest="col4" nameend="col4" align="right">67</entry></row><row rowsep="1"><entry namest="col1" nameend="col4" align="justify">Concentration: Concentration of the stabilizer in the solution left standing</entry></row></tbody></tgroup></table></tables>
Example 65 and Comparison Example 14
003740 ml of a cell extract prepared as in Example 1, 4.5 g of acrylamide, 0.5 g of N,N'-methylenebisacrylamide, and 40 ml of M/20 phosphate buffer (containing 10 g/l of ammonium isobutyrate, pH 6.0) were mixed to form a homogeneous suspension. To this suspension were added 5 ml of a 5% aqueous solution of dimethylaminopropionitrile and 10 ml of a 1.0% aqueous solution of potassium persulfate, and the mixture was maintained at 10°C for 30 minutes to cause polymerization. A mass of cell-containing gel obtained was crushed into small particles, which were thoroughly washed with M/20 phosphate buffer containing 5 g/l of ammonium isobutyrate, pH 7.0, whereby approximately 90 g of an immobilized enzyme are obtained.
0038The washed, immobilized enzyme thus obtained was placed in the same buffer containing 5 g/l of isobutyric acid and left standing at 20°C for 3 days.
0039For comparison purposes, the enzyme was immobilized and washed similarly but with the use of phosphate buffer containing no ammonium isobutyrate, and the resultant immobilized enzyme was left standing at 20°C for 5 days.
0040The nitrile hydration activity levels of the gel samples were measured as follows before and after the respective immobilized enzymes were left standing.
00411 g of immobilized gel was mixed with 5 g of acrylonitrile and 97 ml of M/20 phosphate buffer (pH 7.7), and the mixture was subjected to reaction at 0°C for 20 minutes with stirring. The quantities of acrylamide (AA) in the respective reaction solutions were determined by gas chromatography. The results obtained are set forth in Table 7. <tables id="tabl0007" num="0007"><table frame="all"><title>Table 7</title><tgroup cols="4" colsep="1" rowsep="1"><colspec colnum="1" colname="col1" colwidth="39.37mm" /><colspec colnum="2" colname="col2" colwidth="39.37mm" /><colspec colnum="3" colname="col3" colwidth="39.37mm" /><colspec colnum="4" colname="col4" colwidth="39.37mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" align="center">Experimental Example</entry><entry namest="col2" nameend="col2" align="center">Ammonium Isobutyrate</entry><entry namest="col3" nameend="col3" align="center">Quant.of AA produced (%) before enzyme was left standing</entry><entry namest="col4" nameend="col4" align="center">Quant.of AA produced (%) after enzyme was left standing</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">Example 63</entry><entry namest="col2" nameend="col2" align="left">Immobilized with addition of isobutyric acid + left standing in buffer containing isobutyric acid</entry><entry namest="col3" nameend="col3" align="char" char=".">0.71</entry><entry namest="col4" nameend="col4" align="char" char=".">0.60</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Comparison Example 14</entry><entry namest="col2" nameend="col2" align="left">None</entry><entry namest="col3" nameend="col3" align="char" char=".">0.51</entry><entry namest="col4" nameend="col4" align="char" char=".">0.26</entry></row></tbody></tgroup></table></tables>
Contents2
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO2005054456A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| US5863750A | Cited by | United States of America | Search report |
| US6132985A | Cited by | United States of America | Search report |
| FR2731438A1 | Cited by | France | Search report |
| US6060265A | Cited by | United States of America | Search report |
| GB2018240A | Cites | United Kingdom | – |
| US4001081A | Cites | United States of America | – |
| THE WORLD BIOTECH REPORT 1984, PROCEEDINGS OF BIOTECH '84 EUROPE CONFERENCE,London, May 1984, vol. 1, pages 379-390; P. MONSAN: "Stabilization of enzymeactivity" | Non-patent | – | – |
5 priority claims, no other members on record
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 10104486 | Japan | – | |
| 10104486 | Japan | A | |
| 10104486 | Japan | A | |
| 10104486 | – | – | – |
| JP19860101044 | – | – | – |
23 legal events, as 3 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)732E | 732E | GB | |
| Transmission of propertyTP | TP | FR | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents actLapsedNLV1 | NLV1 | EP | |
| Fr: translation filedET | ET | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0243967
- Publication, DOCDB
- 0243967
- Publication, EPODOC
- EP0243967
- Application
- 87106286
- Application, DOCDB
- 87106286
- Application, EPODOC
- EP19870106286
Titles3
- German
- Verfahren zur Erhaltung der Nitrilhydrierungsaktivität
- English
- Method for preservation of nitrile hydration activity
- French
- Procédé de préservation de l'activité d'hydratation de nitrile
Classification
- CPC, 7
- C12N9/96
- C12N9/78
- Y10S435/832
- Y10S435/84
- Y10S435/843
- Y10S435/859
- Y10S435/872
- IPC, 4
- C12N9 78
- C12N9 96
- C12N11 00
- C12P13 02
Designated states1
- Contracting states, 1
- Netherlands (Kingdom of the)